Track topics on Twitter Track topics that are important to you
Gene therapy is slowly stepping out of its niche, as new scientific insights and lessons learned from early-stage failures have led to several approvals. Now, manufacturing of the viruses used in gene therapy is about to become the next bottleneck. ...
The post Manufacturing: The Next Bottleneck in Gene Therapy appeared first on Labiotech.eu.
Original Article: Manufacturing: The Next Bottleneck in Gene TherapyNEXT ARTICLE
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...